A conversation with Dr. Robert Green of the Harvard Medical School, about the roles genetics and genomics play in understanding the Coronavirus and in treating Covid-19.

Genetics, Immunology, and Covid-19: A Conversation with Dr. Robert Green

TTI/Vanguard is an advanced technology membership for senior-level executives to discuss and evaluate emerging and breakthrough technologies on a two-to-ten-year horizon. The podcast series explores the effects of technologies on current events as well as their longer-range influence on culture and society.

TTI/Vanguard is a wholly-owned subsidiary of Euromoney/Institutional Investor PLC, an international business-to-business information company.

Science

Technology

TTI/Vanguard is an advanced technology membership for senior-level executives to discuss and evaluate emerging and breakthrough technologies on a two-to-ten-year horizon. The podcast series explores the effects of technologies on current events as well as their longer-range influence on culture and society. TTI/Vanguard is a wholly-owned subsidiary of Euromoney/Institutional Investor PLC, an international business-to-business information company.

Share Genetics, Immunology, and Covid-19: A Conversation with Dr. Robert Green

Sign up to save your podcasts

Genetics, Immunology, and Covid-19: A Conversation with Dr. Robert Green

Genetics, Immunology, and Covid-19: A Conversation with Dr. Robert Green